On-site monitoring for the ImmunoSABR project has officially started. Following the completion of remote monitoring at all 11 centers, on-site monitoring visits have been scheduled for 8/11 of the centers between November 24 and December 24. These visits are a key step in ensuring the quality and accuracy of data collection across the project. Sillar (https://sillar-clinical.com/) and CTCM (https://www.ctcm.nl/ ) will be conducting the on-site monitoring visits for the ImmunoSABR project. CTCM will handle the visits for Dutch-speaking sites, while Sillar will oversee the visits at non-Dutch-speaking centers.
List of (planned) completion of monitoring per site:
Site 001_MUMC+ 06-jan-2024
Site 002-NKI 21-Nov-2024
Site 004 KUL 9-Dec-2024
Site 005 SLB 14-Nov-2024
Site 006 UZG 27-Nov-2024
Site 009 COL 21-Nov-2024
Site 014 HUH 3-Dec-2024